Skip to content

MEDIHUBR

Active Private limited companyfounded 2023active for 3 yearsAvenue des Ormes 5, 4000 LiègeKBO/BCE: BE 0799.978.103

Lifetime

3 annual accounts with figures on one time axis
peak €290,564 (2025)
€290,564▲ 142%
peak €176,828 (2025)
€176,828▲ 139%
peak €280,692 (2025)
€280,692▲ 170%
€83,519▲ 4.5%
Board1 name since 2023
1 director
Documentsfilings and deeds
30-01-20261 day before the deadline
2025financial year
Gross margin from €120,291 to €290,564Result from €73,928 to €176,828Registered office moved within Liège 25-09Equity from €103,865 to €280,692Cash from €56,293 to €213,894

Key points

from the 2025 annual accounts

Equity

€280,692 ▲ 170%

MEDIHUBR has made a profit in every financial year since 2023.

Result

€176,828 ▲ 139%
€73,9002024€177,0002025

The result rose in 2025 from €73,928 to €176,828.

Turnover

≈ €440,000 estimated

The accounts state no turnover.

Liquidity

4.95 was 2.90 in 2024

Short-term debts rose from €44,427 to €66,479.

Position in the sector

77.1%

Higher solvency than 80% of companies in human health. Sector median 47.0% · 505 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,274 companies had the same profile as MEDIHUBR has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,274 companies, not a prediction for MEDIHUBR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 29-03-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0799978103
Registered office moved within Liège New registered office: Avenue des Ormes 5, 4000 Liège · Previous registered office: Rue Saint-Gilles 200 Boîte A061, 4000 Liège · Board meeting of 28-08-2025 · Gazette deed
Incorporation Founding capital of €2,500, 100 shares · Founder: · Appointment: (director) · published on 29-03-2023 · Gazette deed
First establishment Avenue des Ormes 5, Liège
All 11 events

Comparable companies

same main activity, similar in size and age
Company
MEDIHUBR Liège €364,211 €290,564 77.1% -
Radiosoft Genappe €364,128 €291,966 79.6% -
ORTHOLIB Namur €380,203 €283,577 97.7% -
Dr. Jan Colpaert Puurs-Sint-Amands €392,392 €275,745 74.8% -
DR. T. GHEYSENS Antwerp €379,933 €259,311 98.7% -
Physio MD Estinnes €419,133 €296,793 11.7% -
Docteur Léva J.M. Liège €392,336 €245,036 94.0% -

These companies have the same main activity as MEDIHUBR: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €364,000 and €419,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 27-03-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.343.319.7634000 Liège, since 27-03-2023
Financial year end
30 June
Peppol
Reachable since 08-01-2026
Company details

Annual accounts to 30-06-2025

€364,211▲ 98.2%
Filing
Filed on 30-01-2026, 1 day before the end of the filing period
Financials

Insights on MEDIHUBR

MEDIHUBR has existed since 2023. The present size dates from 2025. The gross margin rose that year from €120,291 to €290,564.

Solvency rose in 2025 from 56.5% to 77.1% because of the retained profit.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDIHUBR

What is the company number of MEDIHUBR?
The company number of MEDIHUBR is 0799.978.103. The VAT number is the same number with BE in front: BE 0799.978.103.
Where is MEDIHUBR based?
The registered office is at Avenue des Ormes 5, 4000 Liège.Company details
What does MEDIHUBR do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of MEDIHUBR?
MEDIHUBR is a private limited company (BV).
When was MEDIHUBR founded?
MEDIHUBR was founded on 27-03-2023.
Is MEDIHUBR still active?
Yes, MEDIHUBR is an active enterprise in the KBO register.
What is the turnover of MEDIHUBR?
The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €290,564 and 30 comparable companies (NACE 86220). It probably lies between €390,000 and €610,000.Financials
Is MEDIHUBR profitable?
In financial year 2025, MEDIHUBR made a profit of €176,828.
Where can I find the annual accounts of MEDIHUBR?
MEDIHUBR filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDIHUBR due?
MEDIHUBR must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.